
Medigene licences CD40L-CD28 costimulatory switch receptor
Medigene has licences the global exclusive rights for CD40L-CD28 costimulatory switch receptor from the Helmholtz Centre Munich. Financial details...

Dutch State to sell share capital of Intravacc BV
Two years after the establishment of the private company Intravacc BV (Bilthoven, The Netherlands), the sale of the former Netherlands Vaccine...

mbiomics GmbH cashes in €13m in Series A financing
High-Tech Gründerfonds (HTGF) and the state bank Bayern Kapital joined the funding round together with private seed investors.The start-up company...

Insempra and Axxence launch alpha-ionone
Insempra GmbH has launched its first functional ingredient, a biotechnologically produced, 100% natural alpha-Ionone flavour and fragrance ingredient...

Upscaling AAV gene therapy
Mid-March marks the start of the collaboration of Remedium Bio Inc. and Biovial Oy on an AAV gene therapy for osteoarthritis. Rheumatology and...

Hot of the press: new issue of BIOTECH Insight
The current issue of the BIOTECH Insight Newsletter, launched in December 2021 by Deutsche Börse with support of BIOCOM AG, addresses hot topics in...